NYRA Gains Approval in First Step to Add Tunnel at Belmont

The project that will ultimately lead to the construction of a tunnel to the Belmont Park infield and possibly the installation of an artificial surface at the track gained approval from the New York Racing Franchise Oversight Board Wednesday, according to the Daily Racing Form. The board approved the construction of a retaining wall on the backstretch, which would need to precede the tunnel's construction.

Beginning from a planned parking lot on Belmont's backstretch, the tunnel would lead to the track's infield, at approximately the location of the three-quarters pole. The tunnel would provide an access point for construction vehicles to facilitate work on the existing dirt and turf racing surfaces, as well as the potential installation of the artificial surface.

“It's, in essence, building a bridge to get to that 45 acres of land, including what could be community space,” NYRA chief executive David O'Rourke told DRF.

The project to build the tunnel would also require approval by the oversight board. NYRA officials said during the meeting that any projects for the infield area would be discussed at a later date. Construction on the tunnel is not expected to begin until 2022.

The Franchise Oversight Board also approved a project to construct a new building for the Racetrack Chaplaincy and a new health clinic at the track.

The post NYRA Gains Approval in First Step to Add Tunnel at Belmont appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Further Analysis Of March EHV-1 Outbreak Reveals New Variant Of The Disease

In March, eight horses housed at a Pennsylvania show barn were diagnosed with EHV-1 after having elevated temperatures but no other signs of illness. The cause of the outbreak has been found to be a new variant of the EHV-1 H752 genotype. The variant contains the same mutation as the EHV-1 outbreak in France.

EHV-1 can cause respiratory disease in young horses, early death in foals, abortions in mares and occasionally neurological disease. Neurologic issues are fairly uncommon, but can cause the death of the affected horse.

The 31 horses that lived at the affected barn were treated with valacyclovir, and ill horses also received flunixin meglumine and sodium heparin. The investigation team, led by Dr. Nicola Pusterla, believe that the early administration of valacyclovir may have prevented additional horses from falling ill with neurologic complications. Additionally, they note the lack of respiratory symptoms in these cases may be related to the recent administration of EHV vaccinations.

The distribution of the new genotype is not known.

Read the case report here.

Read more at HorseTalk.

The post Further Analysis Of March EHV-1 Outbreak Reveals New Variant Of The Disease appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights